IPCA Laboratories Share Price

₹ 1,972.00

+₹21.90 (1.12%)
1D
Last updated 04 Nov, 2026, 15:59 IST
NSE: IPCALAB
|
Pharmaceuticals

IPCA Laboratories Share Price Today

As of 5 Nov 2026, IPCA Laboratories share price is ₹1,972.00. The stock opened at ₹1,955.00, compared to its previous close of ₹1,950.10. During today's trading session, IPCA Laboratories share price moved in the range of ₹1,955.00 to ₹1,995.00, with an average price of ₹1,975.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,276.10 and a high of ₹2,038.00. On the performance front, IPCA Laboratories share price has increased by 28.89% over the last six months and is up 52.30% on a year-on-year basis.

Share price over the last 1 day rose from 1963.90 to 1972.50, ranging between 1960.70 and 1991.80.
₹1,955.00
1.12% up today
₹1,995.00
1D LOW
1D HIGH

IPCA Laboratories Stock Insights

Latest Earning
Op Profit TrendUp by 41.45% QoQ
Latest Earning
Net Profit TrendUp by 36.65% QoQ
Latest Earning
Revenue TrendUp by 13.34% QoQ
Stock Performance
OutperformingBeat Nifty by 13.79 % in last 3 month
Shareholding Pattern
DIIDII decreased stake by 11.07%
Shareholding Pattern
FIIFII increased stake by 7.46%
Technical Indicators
Volume SpikeVolume is 50.0% above 20-day average on 1 Day interval.
IPCA Laboratories stock performance
Open₹1,955.00
High₹1,995.00
Low₹1,955.00
Prev. close₹1,950.10
IPCA Laboratories trading activity
Volume4,02,858
Average traded price₹1,972.90
Last traded time03:59:20 04 Nov
Last traded quantity3
Circuit
L
H
₹1,577.60
₹2,366.40
52-week
L
H
₹1,276.10
₹2,038.00
Mkt Cap Cr
49,430.46
P/E
35.95
P/B
6.13
ROA
11.15%
ROE
14.15%
ROCE
18.58%
Quick Ratio
1.58
EV/EBITDA
21.5

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Ipca Labs. has underperformed the market
Valuation: 2 out of 5, Expensive
Valuation
Expensive
Ipca Labs. PE is significantly higher than its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Ipca Labs. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,25,150.1638.74.769.61%13.79%18.65%2.3122.17
Divis Laboratories2,64,141.2491.0315.8914.6%15.32%19.56%3.559.98
Torrent Pharmaceuticals1,76,300.5085.729.794.7%11.42%11.37%0.7533.85
Laurus Labs1,25,352.4494.0820.6811.58%22.11%20.91%0.6853.48
Zydus Lifesciences1,23,685.4926.914.568.57%18.59%17.35%0.9116.36
Dr. Reddy's Laboratories1,14,351.2041.442.954.79%7.21%8.58%1.3518.91
Cipla1,12,471.7539.413.186.6%8.18%10.8%2.521.15
Mankind Pharma1,02,315.4045.25.827.82%12.76%14.68%0.7424.9
Aurobindo Pharma97,756.7126.352.586.34%9.25%11.76%1.1512.4
Lupin92,144.5416.574.114.47%23.76%24.88%1.429.76

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

IPCA Laboratories Company Background

ISIN
INE571A01038
Sector Market Cap
₹ 49,430.46 Cr

Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.

IPCA Laboratories Financial Highlights

  • Revenue: IPCA Laboratories reported revenue of ₹9,820.78 crore in FY26 vs ₹9,032.39 crore in FY25. It showed an increase of 8.73% on a yearly basis.
  • Operating Profit: IPCA Laboratories reported an operating profit of ₹1,572.52 crore in FY26 vs ₹1,131.14 crore in FY25. It showed an increase of 39.02% on a year-on-year basis.
  • Net Profit: IPCA Laboratories reported a net profit of ₹1,191.37 crore in FY26 vs ₹787.53 crore in FY25. It showed an increase of 51.28% on a yearly basis.

IPCA Laboratories Quarterly Result Highlights

  • IPCA Laboratories reported revenue of ₹2,813.36 crore in Jun 2026, compared with ₹2,482.22 crore in Mar 2026, representing an increase of 13.34% on a quarter-on-quarter (QoQ) basis.
  • IPCA Laboratories reported an operating profit of ₹572.08 crore in Jun 2026, compared with ₹404.45 crore in Mar 2026, representing an increase of 41.45% on a quarter-on-quarter (QoQ) basis.
  • IPCA Laboratories reported a profit of ₹422.81 crore in Jun 2026, compared with ₹309.40 crore in Mar 2026, reflecting an increase of 36.65% on a QoQ basis.
  • The earnings per share (EPS) of IPCA Laboratories stood at ₹44.98 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
44.72%
FII
11.53%
Other DII
5.53%
Retail and other
7.15%
Mutual funds
31.07%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202510.63%
Mar 202610.63%
Jun 202610.73%
Sep 202611.53%

IPCA Laboratories Investment Returns

1 day
+1.12%
1 week
+2.15%
1 month
+1.48%
1 year
+52.30%
3 years
+103.34%
5 years
+84.83%

IPCA Laboratories Share Price History

IPCA Laboratories share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
04 Nov 26
₹1,955.00 / ₹1,972.00
+1.12%
03 Nov 26
₹1,969.00 / ₹1,950.10
+0.01%
02 Nov 26
₹1,937.40 / ₹1,949.90
+1.15%
30 Oct 26
₹1,945.20 / ₹1,927.80
+0.08%
Show more

IPCA Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹9,646.33₹8,939.59₹7,705.04₹6,244.32
Other Income₹174.45₹92.80₹124.77₹125.62
Total Revenue₹9,820.78₹9,032.39₹7,829.81₹6,369.94
Total Expenses₹8,161.83₹7,696.20₹6,879.39₹5,624.65
Profit Before Tax₹1,572.52₹1,131.14₹842.67₹745.29
Tax₹381.15₹343.61₹313.46₹253.36
Profit After Tax₹1,191.37₹787.53₹529.21₹491.93
EPS - Basic₹44.98₹29.08₹21.57₹18.58
EPS - Diluted₹44.98₹29.08₹21.57₹18.58

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,572.52₹1,131.14₹842.67₹745.29
Income before WC changes₹1,849.87₹1,859.03₹1,332.54₹980.47
Change in Assets-₹280.16-₹192.84-₹185.45₹88.73
Change in Liabilities-₹13.79₹16.38₹93.86-₹39.74
Change in WC-₹293.95-₹176.46-₹91.59₹48.99
Cash flow from Operations₹1,141.97₹1,321.32₹944.65₹805.81
Cash flow from Investing-₹246.77-₹869.50-₹1,291.79-₹725.00
Cash flow from Financing-₹753.53-₹282.98-₹552.55₹507.24
Total Cash Flow₹141.67₹168.84-₹899.69₹588.05
Cash (Start of the year)₹924.63₹755.79₹1,578.98₹990.93
Cash (End of the year)₹1,066.30₹924.63₹755.79₹1,578.98

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹5,996.58₹5,793.51₹5,565.73₹3,437.16
Current Assets₹6,373.61₹5,967.04₹5,535.55₹5,189.27
Total Assets₹12,370.19₹11,760.55₹11,101.28₹8,626.43
Current Liabilities₹2,306.93₹2,386.22₹2,355.64₹1,805.82
Net Current Asset₹4,066.68₹3,580.82₹3,179.91₹3,383.45
Non-Current Liabilities₹539.20₹986.06₹1,018.64₹905.29
Equity Capital₹9,524.06₹8,388.27₹7,727.00₹5,915.32
Total Equity & Liabilities₹12,370.19₹11,760.55₹11,101.28₹8,626.43

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹7,336.75₹6,677.92₹6,166.46₹5,814.62
Other Income₹94.64₹71.29₹111.29₹111.19
Total Revenue₹7,431.39₹6,749.21₹6,277.75₹5,925.81
Total Expenses₹5,868.84₹5,467.90₹5,322.23₹5,175.32
Profit Before Tax₹1,532.13₹999.77₹822.16₹750.49
Tax₹399.61₹349.01₹291.75₹244.79
Profit After Tax₹1,132.52₹650.76₹530.41₹505.70
EPS - Basic₹44.64₹25.65₹20.91₹19.93
EPS - Diluted₹44.64₹25.65₹20.91₹19.93

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,532.13₹999.77₹822.16₹750.49
Income before WC changes₹1,905.74₹1,605.55₹1,221.32₹956.58
Change in Assets-₹296.30₹43.76-₹160.96₹70.75
Change in Liabilities₹162.62₹49.51₹47.10-₹49.79
Change in WC-₹133.68₹93.27-₹113.86₹20.96
Cash flow from Operations₹1,378.12₹1,374.07₹830.51₹762.29
Cash flow from Investing-₹696.99-₹738.81-₹1,355.18-₹709.61
Cash flow from Financing-₹745.21-₹428.44-₹464.88₹506.38
Total Cash Flow-₹64.08₹206.82-₹989.55₹559.06
Cash (Start of the year)₹722.10₹515.28₹1,504.83₹945.77
Cash (End of the year)₹658.02₹722.10₹515.28₹1,504.83

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹5,780.50₹5,290.98₹5,149.38₹3,571.82
Current Assets₹3,995.00₹3,779.94₹3,509.89₹4,875.15
Total Assets₹9,775.50₹9,070.92₹8,659.27₹8,446.97
Current Liabilities₹1,418.75₹1,419.53₹1,520.17₹1,677.78
Net Current Asset₹2,576.25₹2,360.41₹1,989.72₹3,197.37
Non-Current Liabilities₹377.40₹759.77₹790.39₹891.89
Equity Capital₹7,979.35₹6,891.62₹6,348.71₹5,877.30
Total Equity & Liabilities₹9,775.50₹9,070.92₹8,659.27₹8,446.97
* All values are in INR Crore
IPCA Laboratories market depth
Bid quantityBid priceAsk priceAsk quantity
561197200
0000
0000
0000
0000
Total bid quantity561
Total ask quantity0
IPCA Laboratories technical summary
Bearish indicators1
Neutral indicators5
Bullish indicators2
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
53.54
Neutral
ATR (14)
71.41
Neutral
STOCH(9,6)
67.79
Neutral
STOCH RSI (14)
84.01
Bearish
ADX(9)
16.75
Bullish
UO(9)
38.54
Neutral
ROC(12)
1.93
Bullish
WillR(14)
-22.28
Neutral
Period
Simple value
Exponential vaue
5D
1945.2
1951.87
10D
1943.27
1941.22
20D
1921.74
1934.11
50D
1944.69
1912.46
100D
1845.21
1846.12
Volume trend — traded volume by day
4 Nov4L
3 Nov3L
2 Nov2L
30 Oct2L
29 Oct1L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

IPCA Laboratories
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in IPCA Laboratories

Fund name
AUM
DSP Healthcare Fund
8.55%
HDFC Pharma and Healthcare Fund
4.80%
Tata Nifty MidSmall Healthcare Index Fund
3.97%

IPCA Laboratories Returns Calculator

Ex-date: 07 Aug 2026

IPCA Laboratories Latest News

2 months ago
PTC Industries, IPCA Labs, Physicswallah shares surge amid spike in volumes; check full list
Showing news item 1 of 1

Top Gainers

SAREGAMA Share Price
₹636.80
+74.6 (+13.27%)
APLLTD Share Price
₹906.70
+103.9 (+12.94%)
GMDCLTD Share Price
₹469.20
+43.6 (+10.24%)
ZEEL Share Price
₹67.87
+6.2 (+10.05%)
REDINGTON Share Price
₹366.75
+31.5 (+9.4%)
See more

Top Losers

SKFINDIA Share Price
₹1395.30
-76.6 (-5.2%)
AIAENG Share Price
₹3219.80
-169.9 (-5.01%)
MTARTECH Share Price
₹6036.50
-276 (-4.37%)
ZYDUSLIFE Share Price
₹1188.10
-52.5 (-4.23%)
ALKYLAMINE Share Price
₹1589.50
-69.3 (-4.18%)
See more

IPCA Laboratories Share Price FAQs

Please be aware that IPCA Laboratories stock prices are subject to continuous fluctuations due to various factors.